Vraylar (cariprazine) has several important drug interactions, most of them tied to how your body processes the medication through a specific liver enzyme called CYP3A4. Certain drugs speed up or slow down this enzyme, which can make Vraylar either dangerously strong or ineffective. Beyond prescription interactions, a common herbal supplement and even alcohol can cause problems.
Strong CYP3A4 Inhibitors Require a Dose Cut
Your liver breaks down Vraylar using an enzyme called CYP3A4. Drugs that block this enzyme cause Vraylar to build up in your bloodstream, intensifying both its effects and its side effects. The two most commonly cited examples are the antifungal medications itraconazole and ketoconazole, but the category also includes certain HIV medications and the antibiotic clarithromycin.
If you’re already on a stable dose of Vraylar and need to start one of these drugs, the FDA labeling calls for cutting the Vraylar dose in half. Someone on 4.5 mg daily, for instance, would drop to 1.5 mg or 3 mg. If you’re only taking 1.5 mg, the schedule shifts to every other day instead of daily. The interaction is significant enough that your prescriber needs to know about any new medications before you start them.
Strong CYP3A4 Inducers Are Not Recommended
On the opposite end, some drugs rev up CYP3A4 activity, which clears Vraylar from your system faster than intended. This can leave you with blood levels too low to be therapeutic. The FDA specifically names rifampin (an antibiotic used for tuberculosis) and carbamazepine (a seizure and mood-stabilizing medication) as strong CYP3A4 inducers that should not be taken alongside Vraylar.
The reasoning is straightforward: CYP3A4 is responsible for both creating and eliminating Vraylar’s active metabolites. When an inducer speeds up that process, the net effect on drug levels in your body becomes unpredictable. Because this hasn’t been fully studied, the FDA’s position is simply to avoid the combination rather than try to adjust the dose.
St. John’s Wort
St. John’s Wort, a popular over-the-counter herbal supplement used for mood support, is a known CYP3A4 inducer. It falls into the same category as rifampin and carbamazepine: it can reduce Vraylar’s effectiveness by speeding up how quickly your body metabolizes it. The Canadian product monograph for Vraylar explicitly lists St. John’s Wort among the substances that should not be taken with the medication. This is an easy interaction to miss because many people don’t think of herbal supplements as “real” drugs, but the enzyme effect is real and clinically meaningful.
Alcohol and Other Sedating Substances
Vraylar can cause drowsiness and impair your thinking and motor skills on its own. Combining it with alcohol, benzodiazepines (like lorazepam or alprazolam), opioids, or sleep medications compounds that sedation. The practical risk is impaired coordination, slowed reaction time, and excessive drowsiness that can affect your ability to drive or function safely. While the FDA labeling doesn’t list alcohol as a hard contraindication, the combination is strongly discouraged for these reasons.
Blood Pressure Medications
Vraylar can lower blood pressure, particularly when you stand up quickly, a phenomenon called orthostatic hypotension. If you’re already taking medication for high blood pressure, adding Vraylar may amplify that drop. This doesn’t mean you can’t take both, but the combination increases your risk of dizziness, lightheadedness, and fainting, especially in the first few weeks. Staying hydrated and standing up slowly helps, and your prescriber may want to monitor your blood pressure more closely during the adjustment period.
Heat Exposure Is a Serious Concern
This isn’t a drug interaction, but it’s a lifestyle factor that catches many people off guard. Antipsychotics like Vraylar interfere with your body’s ability to regulate temperature. Specifically, they can impair sweating, which is your primary cooling mechanism. The CDC notes that antipsychotics also reduce thirst sensation and cause sedation, both of which make it harder to recognize and respond to overheating.
During hot weather or intense exercise, this creates a real risk of heat exhaustion or heat stroke. If you take Vraylar, you should be especially careful about staying hydrated, limiting time in extreme heat, and avoiding strenuous outdoor activity on the hottest days. This applies year-round if you work in hot environments or exercise heavily.
Who Should Not Take Vraylar at All
Vraylar carries the FDA’s most serious warning, a black box warning, about use in elderly patients with dementia-related psychosis. This population faces an increased risk of death when treated with any antipsychotic medication, and Vraylar is not approved for this use. The warning applies broadly to the entire class of antipsychotic drugs, not just Vraylar specifically, but it’s the single most prominent safety concern on the label.
Additionally, the effects of Vraylar in people with significant kidney or liver impairment haven’t been well established. Because the drug depends heavily on liver metabolism through CYP3A4, compromised liver function could alter drug levels unpredictably. If you have kidney or liver disease, that’s critical information for your prescriber to factor into the decision about whether Vraylar is appropriate for you.